CN102579416A - 卡莫司汀的新用途 - Google Patents
卡莫司汀的新用途 Download PDFInfo
- Publication number
- CN102579416A CN102579416A CN2012100449168A CN201210044916A CN102579416A CN 102579416 A CN102579416 A CN 102579416A CN 2012100449168 A CN2012100449168 A CN 2012100449168A CN 201210044916 A CN201210044916 A CN 201210044916A CN 102579416 A CN102579416 A CN 102579416A
- Authority
- CN
- China
- Prior art keywords
- carmustine
- nose
- rat
- touches
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210044916 CN102579416B (zh) | 2012-02-24 | 2012-02-24 | 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210044916 CN102579416B (zh) | 2012-02-24 | 2012-02-24 | 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102579416A true CN102579416A (zh) | 2012-07-18 |
CN102579416B CN102579416B (zh) | 2013-10-30 |
Family
ID=46469028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210044916 Active CN102579416B (zh) | 2012-02-24 | 2012-02-24 | 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102579416B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101032475A (zh) * | 2007-04-03 | 2007-09-12 | 北京世纪博康医药科技有限公司 | 一种卡莫司汀的药用组合物、制备方法及用途 |
CN101444506A (zh) * | 2008-12-30 | 2009-06-03 | 北京大学 | 雷帕霉素在制备治疗吗啡类药物成瘾的药物上的用途 |
-
2012
- 2012-02-24 CN CN 201210044916 patent/CN102579416B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101032475A (zh) * | 2007-04-03 | 2007-09-12 | 北京世纪博康医药科技有限公司 | 一种卡莫司汀的药用组合物、制备方法及用途 |
CN101444506A (zh) * | 2008-12-30 | 2009-06-03 | 北京大学 | 雷帕霉素在制备治疗吗啡类药物成瘾的药物上的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN102579416B (zh) | 2013-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fairbairn et al. | Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic | |
Rzasa Lynn et al. | Naloxone dosage for opioid reversal: current evidence and clinical implications | |
Volkow | America’s addiction to opioids: Heroin and prescription drug abuse | |
Veilleux et al. | A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction | |
Derendorf et al. | Rowland and Tozer's clinical pharmacokinetics and pharmacodynamics: concepts and applications | |
Schwartz et al. | Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009 | |
Galinski et al. | Management of severe acute pain in emergency settings: ketamine reduces morphine consumption | |
Yue et al. | The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats | |
Aceto et al. | MDAN‐21: a bivalent opioid ligand containing mu‐agonist and delta‐antagonist pharmacophores and its effects in rhesus monkeys | |
Levy | Clinical effects and lethal and forensic aspects of propofol | |
Volkow | Prescription opioid and heroin abuse | |
Gerak et al. | Reversal and prevention of the respiratory-depressant effects of heroin by the novel μ-opioid receptor antagonist methocinnamox in rhesus monkeys | |
Dedden et al. | Pharmacy-managed program for home treatment of deep vein thrombosis with enoxaparin | |
Dart et al. | A randomized, double-blind, placebo-controlled trial of a highly purified equine F (ab) 2 antibody black widow spider antivenom | |
Gerak et al. | Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys | |
CN101827522A (zh) | 持续释放氨基吡啶组合物的使用方法 | |
Crystal et al. | Pharmacokinetic properties of an FDA‐approved intranasal nalmefene formulation for the treatment of opioid overdose | |
Feng et al. | Machine-learning analysis of opioid use disorder informed by MOR, DOR, KOR, NOR and ZOR-based interactome networks | |
CN102579416B (zh) | 卡莫司汀在制备预防和/或治疗精神活性物质的依赖与复吸的药物中的应用 | |
Lehmann et al. | Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine | |
Arboleda et al. | Cannabinoids in disorders of gut-brain interaction and gastrointestinal motility | |
CN106038522A (zh) | 大黄酸在制备抗抑郁症药物中的用途 | |
Ostwal et al. | Reversal of opioid-induced toxicity | |
Salani et al. | Heroin use | |
CN103622988B (zh) | 虫草素在制备抗抑郁症的药物中的用途及其制备而得的快速抗抑郁症药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Longchuan Inventor before: Yu Longchuan Inventor before: Kong Qingyao |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YU LONGCHUAN KONG QINGYAO TO: YU LONGCHUAN |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: KONG QINGYAO Effective date: 20130328 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130328 Address after: 100091 Beijing city Haidian District Old Summer Palace West Yan Bei yuan 316-308 Applicant after: Yu Longchuan Address before: 100091 Beijing city Haidian District Old Summer Palace West Yan Bei yuan 316-308 Applicant before: Yu Longchuan Applicant before: Kong Qingyao |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |